Rag1-KO(Rag1-EGFP)

모델명

B6.129S-Rag1tm1(loxP-EGFP-PolyA-loxP-Neo-loxP)Smoc

카탈로그

NM-KI-00069

모델 상태

Repository Live

PDF 받기

유전자 요약

Gene Symbol
Rag1

모델 설명

A loxP-EGFP-PolyA-loxP-Neo-loxP expression cassette was knocked into the Rag1 gene start codon site. As a Rag1 knockout mouse model, this stain can be used in subcutaneous inoculation of liver cancer tissues and tumor cells. Tumors can esaily form and grow. The amount of T and B lymphocytes in peripheral blood of mice was extremely low tested by FACS, which was comparable to or lower than that of Nude mice, and there was a significant difference compared with wild type mice. The pathological sections of HE staining of tumor tissues showed that the tumor sections of Rag1 KO mice and Nude mice were similar. This strain has the potential to replace Nude, NOD-SCID mice as a tumor-bearing mouse model.
신청분야:Immunodeficiency,tumor-bearing model

검증 데이터

rag1.jpg

Fig.1 Construction strategy of Rag1-KO.

rag1-rag2-外周血.png

Fig.2 Loss of T and B cells in peripheral blood of Rag1-KO and Rag2-KO mice.

rag1-rag2-脾脏.png

Fig.3 Loss of T and B cells in Spleen of Rag1-KO and Rag2-KO mice.

rag1-rag2-胸腺.png

Fig.4 Loss of T and B cells in thymus of Rag1-KO and Rag2-KO mice.

image.png

Fig.5 Detection of EGFP expression in CD45+ cells in spleen, blood, thymus, and bone marrow of 8.7-week-old female WT and HO Rag1-KO(Rag1-EGFP) mice.

image.png

Fig.6 Detection of mouse IgG(A) and IgM(B) expression in serum by ELISA. (male, 5~6wks, n=3)

Abbr. HO, homozygous; WT, wild type; N.D. not detected.

Rag1-Rag2.png

Fig.7 Tumorigenicity results following inoculation with A549 tumor cells in Balb/c nude, NOD-Scid, Rag1-KO and Rag2-KO mice.


Table1. Complete blood count of Rag1-KO (Rag1-EGFP) mice

image.png

Table 2. Serum biochemical analysis of Rag1-KO (Rag1-EGFP) mice.

image.png




당신은 또한 좋아할 수 있습니다

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

조회

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

조회

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

조회